119th Congress · introduced in the House · Feb 6, 2025
Modern Authentication of Pharmaceuticals Act of 2025
Official title from Congress.gov
Latest action (Feb 6, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Feb 6, 2025)
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Sponsor introductory remarks on measure. (CR H519)
Introduced in House
Actions from Congress.gov, newest first.
Drug safety, medical device, and laboratory regulation · Drug trafficking and controlled substances · Prescription drugs · Supply chain
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
No matching lobbying reports found within coverage